AKAP11: A Protein with Unique Structure and Potential as A Drug Target Or Biomarker

Target Name: AKAP11

NCBI ID: G11215

AKAP11

AKAP11: A Protein with Unique Structure and Potential as A Drug Target Or Biomarker

AKAP11 (also known as AKA11_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the A-kinase anchored subfamily of protein tyrosine kinases (AKAPs), which are a family of transmembrane proteins that play a key role in intracellular signaling.

The AKAP11 protein is known for its unique structure, which consists of a catalytic active site, a regulatory domain, and a carboxylic acid termini. The catalytic active site is located at the center of the protein and is responsible for the catalytic activity of the enzyme. The regulatory domain is located at the N-terminus of the protein and is responsible for regulating the activity of the enzyme. The carboxylic acid termini are located at the C-terminus of the protein and are responsible for the stability and interactions of the protein with other molecules.

AKAP11 has been shown to play a key role in a variety of physiological processes in the human body, including the regulation of cell proliferation, the development and maintenance of tissues, and the regulation of signaling pathways. It is also has been shown to be involved in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Due to its unique structure and its involvement in a variety of important biological processes, AKAP11 has been identified as a potential drug target or biomarker. Researchers have been studying the AKAP11 protein to understand its function and to identify potential targets for drug development.

One of the main advantages of AKAP11 as a drug target is its accessibility. The protein is expressed in a variety of tissues throughout the body and can be targeted directly by small molecules. Additionally, the protein is well-studied and has a clear mechanism of action, which makes it an attractive target for drug development.

Another advantage of AKAP11 is its potential to act as a biomarker. The protein is expressed in a variety of tissues and can be used as a protein biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Additionally, the protein is well-stable and can be used for a long period of time, which makes it an attractive option for use as a biomarker.

In addition to its potential as a drug target or biomarker, AKAP11 is also of interest to researchers as a potential therapeutic agent. Studies have shown that inhibiting the activity of AKAP11 has been effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Additionally, by understanding the mechanism of action of AKAP11, researchers may be able to identify new targets for therapeutic intervention.

Overall, AKAP11 is a protein that has the potential to be a drug target or biomarker. Its unique structure and its involvement in a variety of important biological processes make it an attractive target for drug development. Additionally, its potential as a biomarker and therapeutic agent make it a promising target for research in a variety of diseases.

It is important to note that this article is for informational purposes only and should not be taken as medical advice.

The discovery and understanding of AKAP11 is a testament to the power of basic research and the dedication of scientists to understanding the complex mechanisms of life. As research continues to advance, it is likely that the full potential of AKAP11 will be realized and its role in the treatment of human disease will continue to grow.

Protein Name: A-kinase Anchoring Protein 11

Functions: Binds to type II regulatory subunits of protein kinase A and anchors/targets them

The "AKAP11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AKAP11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets